Researcher profile · Semantic Scholar

A. Cavey

h-index: 12
Works: 34
Citations: 870

Most-cited papers

Serum antibodies in epilepsy and seizure-associated disorders
K. McKnight, Yu-Wu Jiang, Y. Hart, A. Cavey +6 more
2005Neurology247 citations
Semantic Scholar
Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.
T. Arun, V. Tomassini, E. Sbardella, M. D. de Ruiter +10 more
2013Brain : a journal of neurology136 citations Open access
Semantic Scholar
Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection
A. Mentzer, D. O'Connor, S. Bibi, I. Chelysheva +65 more
2022Nature Medicine84 citations Open access
Semantic Scholar
Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis
S. Messina, R. Mariano, A. Roca-Fernández, A. Cavey +5 more
2020medRxiv59 citations Open access
Semantic Scholar
Multiple sclerosis in Japan appears to be a milder disease compared to the UK
L. Piccolo, G. Kumar, I. Nakashima, T. Misu +6 more
2015Journal of Neurology56 citations
Semantic Scholar
Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels
C. Stagg, B. Lang, J. Best, K. McKnight +4 more
2010Epilepsia51 citations Open access
Semantic Scholar
A type 2 biomarker separates relapsing-remitting from secondary progressive multiple sclerosis
A. Dickens, J. Larkin, J. Griffin, A. Cavey +8 more
2014Neurology50 citations Open access
Semantic Scholar
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
M. Juryńczyk, Fay Probert, T. Yeo, G. Tackley +13 more
2017Acta Neuropathologica Communications49 citations Open access
Semantic Scholar
Classifying the antibody-negative NMO syndromes
T. Yeo, Fay Probert, M. Juryńczyk, M. Sealey +7 more
2019Neurology: Neuroimmunology & Neuroinflammation32 citations Open access
Semantic Scholar
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosis
S. Coe, J. Cossington, J. Collett, A. Soundy +13 more
2019Journal of Neurology Neurosurgery & Psychiatry23 citations Open access
Semantic Scholar
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
P. Rodríguez-Cruz, Lucy Matthews, M. Boggild, A. Cavey +11 more
2016JAMA Neurology19 citations Open access
Semantic Scholar
Nurse led telephone assessment of expanded disability status scale assessment in MS patients at high levels of disability.
S. Huda, A. Cavey, A. Izat, P. Mattison +2 more
2016Journal of Neurological Sciences13 citations
Semantic Scholar
An In-vivo 1H-MRS short-echo time technique at 7T: Quantification of metabolites in chronic multiple sclerosis and neuromyelitis optica brain lesions and normal appearing brain tissue
G. Tackley, Y. Kong, R. Minne, S. Messina +10 more
2021NeuroImage9 citations Open access
Semantic Scholar
The influence of smoking on the pattern of disability and relapse risk in AQP4-positive Neuromyelitis Optica Spectrum Disorder, MOG-Ab Disease and Multiple Sclerosis.
S. Messina, R. Mariano, R. Geraldes, Su-Hyun Kim +13 more
2021Multiple Sclerosis and Related Disorders9 citations Open access
Semantic Scholar
Hydration and independence in activities of daily living in people with multiple sclerosis: a pilot investigation
J. Collett, H. Dawes, A. Cavey, A. Meaney +3 more
2011Disability and Rehabilitation8 citations
Semantic Scholar
Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS)
R. Dobson, M. Craner, Ed Waddingham, A. Miller +25 more
2022Journal of Neurology Neurosurgery & Psychiatry6 citations Open access
Semantic Scholar
A protocol for a randomised double-blind placebo-controlled feasibility study to determine whether the daily consumption of flavonoid-rich pure cocoa has the potential to reduce fatigue in people with relapsing and remitting multiple sclerosis (RRMS)
S. Coe, J. Collett, H. Izadi, D. Wade +7 more
2018Pilot and Feasibility Studies6 citations Open access
Semantic Scholar
OPTIMISE: MS study protocol: a pragmatic, prospective observational study to address the need for, and challenges with, real world pharmacovigilance in multiple sclerosis
R. Dobson, M. Craner, Ed Waddingham, A. Miller +13 more
2021BMJ Open5 citations Open access
Semantic Scholar
The evaluation of a novel "goat serum" therapy (Aimspro) in multiple sclerosis
G. Burke, A. Cavey, P. Matthews, Jacqueline Palace
20054 citations
Semantic Scholar
Physical Activity and Fatigue in Multiple Sclerosis: Secondary Outcomes from a Double-blinded Randomized Controlled Trial of Cocoa Flavonoid Drinks
M. Mansoubi, S. Coe, J. Cossington, J. Collet +6 more
2021Translational Medicine and Exercise Prescription2 citations Open access
Semantic Scholar
The clinical phenotype of non-paraneoplastic voltage gated potassium channel antibody (VGKC Ab) associated CNS disease
A. Seymour, Jacqueline Palace, B. Lang, L. Clover +2 more
20042 citations
Semantic Scholar
Spinal cord involvement in MOGAD, AQP4-Ab NMOSD & MS
R. Mariano, S. Messina, A. Roca-Fernández, A. Cavey +4 more
2022Journal of Neurology Neurosurgery & Psychiatry1 citations
Semantic Scholar
Multi-axis metabolic 3D modelling identifies a distinct phenotype in double negative demyelinating disease
Yi-Nuo Zang, Daniel C. Anthony, T. Yeo, A. Cavey +18 more
2026Journal of Neuroinflammation0 citations Open access
Semantic Scholar
An optimal 1H-MRS technique at 7T: Proof-of-principle in Chronic Multiple Sclerosis and Neuromyelitis Optica Brain Lesions and Normal Appearing Brain Tissue.
G. Tackley, Y. Kong, R. Minne, S. Messina +10 more
2020medRxiv0 citations Open access
Semantic Scholar
Cervical cord atrophy in AQP4-Ab NMOSD, MOG-Ab disease & MS
R. Mariano, S. Messina, A. Roca-Fernández, A. Cavey +5 more
20190 citations
Semantic Scholar
Smoking on disability accumulation in neuromyelitis optica and multiple sclerosis
S. Messina, R. Geraldes, Y. Y. Chua, Jennifer Taylor +9 more
20170 citations
Semantic Scholar
Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
M. Juryńczyk, Fay Probert, T. Yeo, G. Tackley +13 more
2017Acta Neuropathologica Communications0 citations Open access
Semantic Scholar
ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride
T. Arun, Valentina Tomassini, E. Sbardella, M. D. de Ruiter +7 more
20130 citations
Semantic Scholar
ASIC1 Blockade in Primary Progressive Multiple Sclerosis: Evidence of Neuroprotection with Amiloride (S31.002)
T. Arun, V. Tomassini, E. Sbardella, M. B. D. Ruiter +7 more
2013Neurology0 citations
Semantic Scholar
The association between sunlight hours and month of birth in multiple sclerosis patients across UK regions
Matthews Lae., M. Oppenheimer, A. Cavey, N. Evangelou +10 more
20120 citations
Semantic Scholar
Early clinical predictors of disease progression in relapsing-remitting multiple sclerosis: the Oxford UK cohort
B. Wakerley, S. Ryan, A. Cavey, Jacqueline Palace
20110 citations
Semantic Scholar
SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
C. Stagg, B. Lang, J. Hest, A. Cavey +8 more
20090 citations
Semantic Scholar
Running a mitoxantrone service for multiple sclerosis
M. Craner, A. Weir, A. Cavey, J. Palace
20060 citations
Semantic Scholar
Evaluating the feasibility of a real world pharmacovigilance study Evaluating the feasibility of a real world pharmacovigilance study (OPTIMISE:MS) (OPTIMISE:MS)
R. Dobson, M. Craner, Ed Waddingham, A. Miller +26 more
0 citations
Semantic Scholar

M. Craner

×7

S. Messina×7

R. Everett×6

Lucy Matthews×5

R. Mariano×5

M. Juryńczyk×5

A. Vincent×5

N. Evangelou×5